Bahija Jallal, Immunocore 🇬🇧 | Commercial, Diversity, and AI | E14

We’re super privileged to chat online with Bahija Jallal, the CEO of Immunocore. Immunocore is the largest biotech in the UK and the 5th largest in Europe with a market cap of just over 3 billion dollars. We talk about how Immunocore has helped thousands of cancer patients and has become a commercial biotech. We also talk about why she thinks gender and race diversity are a business case and how AI is changing protein and biologics engineering. 💎 ABOUT THE SPEAKERI’ve “known” Bahija for over 10 years, after reading her profile in a student pharma magazine when I was studying bioengineering in France. At that time, she was head of MedImmune and SVP R&D at AstraZeneca. Now as the CEO of Immunocore, with their pioneering T cell receptor platform, she has helped to bring incredible treatments for cancer patients to market. 🔗 LINKS MENTIONED- Bahija on the Breakthrough Labs podcast - open.spotify.com/episode/2X4xedUdJid9GeioRSkCr… Immatics builds on its PRAME Success (and competes with Immunocore) - [OncologyPipeline.com](oncologypipeline.com/apexonco/immatics-builds-…)
- The 25 Most Valuable Biotech Companies in Europe in 2025: ⁠flot.bio/most-valuable-biotech-companies-europ… (flot.bio/most-valuable-biotech-companies-europ…)📜 TRANSCRIPTRead the full transcript here: flot.bio/episode/bahija-jallal-immunocore/🫶 FOLLOW US- Newsletter: eepurl.com/h_fnmH- LinkedIn: linkedin.com/company/flot-bio/- X (Twitter): x.com/FlotBio🎙️ ABOUT FLOT.BIOFlot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 15k monthly views. Free.⭐️ SPONSORSHIPReady to amplify your brand to influential leaders in biotech and biopharma? Contact nick@flot.bio and unlock sponsorship opportunities in our podcasts!🙏 LIKE/FOLLOW/REVIEWDid you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.⏰ TIMESTAMPS
[00:00:00] Intro
[00:00:34] Welcome
[00:01:46] Immunocore’s life-changing cancer drug
[00:07:40] Commercializing Immunocore
[00:13:46] Explaining the TCR technology
[00:20:40] Targeting tumors with PRAME
[00:23:26] Immunocore now and then
[00:35:37] Why Bahija chose Immunocore
[00:40:22] Top lessons from Bahija Jallal
[00:45:48] How is risk appetite connected to innovation?
[00:49:10] Diversity in biotech
[01:00:59] Biological innovation
[01:05:49] AI in protein engineering optimization
[01:14:42] Thanks for listening